Loading candles…
Dipna Pharmachem Ltd, incorporated in 2011 and headquartered in Ahmedabad, operates in the pharmaceutical industry in India. The company is engaged in the trading and distribution of pharmaceutical raw materials, including active pharmaceutical ingredients (APIs), excipients, and specialty chemicals. Serving as an intermediary in the pharmaceutical supply chain, it caters primarily to formulation manufacturers across India. The company focuses on sourcing quality products and ensuring timely delivery to its clients. Dipna Pharmachem Ltd does not have publicly listed shares, subsidiaries, or notable projects documented.
This page is a live market overview for DIPNA PHARMACHEM LIMITED (DPL) on the BSE. As a listed security, DIPNA PHARMACHEM LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for DPL before placing trades on tick2trade.
As of the latest feed, DPL last traded at ₹4.89 on BSE, up ₹0.43 (9.64%) from the previous close of ₹4.46. Today's session range is ₹4.46 – ₹4.96, against a 52-week band of ₹3.9 – ₹25. Traded volume today stands at 1.53L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for DPL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether DPL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for DIPNA PHARMACHEM LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in DPL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated DPL option chain page linked from this overview.
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.